Table 3.
PASI 90, PASI 100, and PGA Rates According to PGA Score at Time of Switching from Ustekinumab to Brodalumab
PGA at Treatment Switch | PASI 90 Week 36 | PASI 100 Week 36 | PGA Success Week 12 | PGA Success Week 36 |
---|---|---|---|---|
2 (n=53) | 41 (77.4%) | 27 (50.9%) | 27 (50.9%) | 27 (50.9%) |
3 (n=49) | 24 (49.0%) | 16 (32.7%) | 28 (57.1) | 27 (55.1%) |
4/5 (n=18) | 6 (33.3%) | 2 (11.1%) | 5 (27.8%) | 6 (33.3%) |
Abbreviations: PGA, physician’s global assessment; PASI, psoriasis area and severity index.